Molecular Neurobiology, Department of Psychiatry, Ludwig Maximilian University of Munich, Germany, Nussbaumstr. 7, Munich, 80336, Germany.
Systasy Bioscience GmbH, Adams-Lehmann-Str. 56, Munich, 80797, Germany.
Sci Rep. 2018 May 25;8(1):8137. doi: 10.1038/s41598-018-26401-9.
G protein-coupled receptors (GPCRs) are the largest class of cell surface receptors and are implicated in the physiological regulation of many biological processes. The high diversity of GPCRs and their physiological functions make them primary targets for therapeutic drugs. For the generation of novel compounds, however, selectivity towards a given target is a critical issue in drug development as structural similarities between members of GPCR subfamilies exist. Therefore, the activities of multiple GPCRs that are both closely and distantly related to assess compound selectivity need to be tested simultaneously. Here, we present a cell-based multiplexed GPCR activity assay, termed GPCRprofiler, which uses a β-arrestin recruitment strategy and combines split TEV protein-protein interaction and EXT-based barcode technologies. This approach enables simultaneous measurements of receptor activities of multiple GPCR-ligand combinations by applying massively parallelized reporter assays. In proof-of-principle experiments covering 19 different GPCRs, both the specificity of endogenous agonists and the polypharmacological effects of two known antipsychotics on GPCR activities were demonstrated. Technically, normalization of barcode reporters across individual assays allows quantitative pharmacological assays in a parallelized manner. In summary, the GPCRprofiler technique constitutes a flexible and scalable approach, which enables simultaneous profiling of compound actions on multiple receptor activities in living cells.
G 蛋白偶联受体(GPCRs)是细胞表面受体中最大的一类,参与许多生理过程的调节。GPCRs 的高度多样性及其生理功能使其成为治疗药物的主要靶点。然而,对于新型化合物的产生,针对特定靶标的选择性是药物开发中的一个关键问题,因为 GPCR 亚家族成员之间存在结构相似性。因此,需要同时测试与评估化合物选择性密切相关和远相关的多种 GPCR 的活性。在这里,我们提出了一种基于细胞的多重 GPCR 活性测定方法,称为 GPCRprofiler,它使用β-arrestin 募集策略,并结合了分裂 TEV 蛋白-蛋白相互作用和基于 EXT 的条形码技术。通过应用大规模平行报告基因测定,该方法能够同时测量多种 GPCR-配体组合的受体活性。在涵盖 19 种不同 GPCR 的原理验证实验中,证明了内源性激动剂的特异性以及两种已知抗精神病药对 GPCR 活性的多药理学作用。在技术上,通过跨单个测定对条形码报告进行归一化,允许以平行方式进行定量药理学测定。总之,GPCRprofiler 技术是一种灵活且可扩展的方法,可在活细胞中同时对多种受体活性上的化合物作用进行分析。